DLHC
Undervalued by 256.8% based on the discounted cash flow analysis.
Market cap | $125.66 Million |
---|---|
Enterprise Value | $304.73 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.11 |
Beta | 1.14 |
Outstanding Shares | 14,232,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 51.01 |
---|---|
PEG | -27.25 |
Price to Sales | 0.15 |
Price to Book Ratio | 0.59 |
Enterprise Value to Revenue | 0.77 |
Enterprise Value to EBIT | 12.77 |
Enterprise Value to Net Income | 41 |
Total Debt to Enterprise | 0.59 |
Debt to Equity | 1.61 |
No data
No data
DLH is a comprehensive health solutions and services provider that delivers a full range of technology-enabled health services across various civilian agencies, the military health system, and the Veterans Administration. The Company's s...